Menu
 
Research menu
Jump to menu

Publications:  Prof Ahuva Nissim

Vinci C, Infantino M, Raturi S, Tindell A, Topping LM, Strollo R, Amital H, Shoenfeld Y et al.(2020). Immunoglobulin A antibodies to oxidized collagen type II as a potential biomarker for the stratification of spondyloarthritis from rheumatoid arthritis. Scandinavian Journal of Rheumatology vol. 49, (4) 281-291.
10.1080/03009742.2020.1713395
Topping LM, Thomas BL, Rhys HI, Tremoleda JL, Foster M, Seed M, Voisin MB, Vinci C et al.(2020). Targeting Extracellular Vesicles to the Arthritic Joint Using a Damaged Cartilage-Specific Antibody. Frontiers in Immunology vol. 11,
10.3389/fimmu.2020.00010
https://qmro.qmul.ac.uk/xmlui/handle/123456789/63161
Strollo R, Vinci C, Napoli N, Fioriti E, Maddaloni E, Åkerman L, Casas R, Pozzilli P et al.(2019). Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies. Diabetes Metab Res Rev vol. 35, (4)
10.1002/dmrr.3132
Smallwood MJ, Nissim A, Knight AR, Whiteman M, Haigh R, Winyard PG(2018). Oxidative stress in autoimmune rheumatic diseases. Free Radical Biology and Medicine vol. 125, 3-14.
10.1016/j.freeradbiomed.2018.05.086
Strollo R, Vinci C, Napoli N, Pozzilli P, Ludvigsson J, Nissim A(2017). Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children. Diabetologia vol. 60, (8) 1467-1474.
10.1007/s00125-017-4296-1
Strollo R, Vinci C, Napoli N, Pozzilli P, Ludvigsson J, Nissim A (2017). Antibodies to Posttranslationally Modified Insulin for Prediction of Type 1 Diabetes in Children. DIABETES. vol. 66, A58-A58.
Nissim A, Hughes C, Faurholm B, Lim NH, Vinchi C, Topping LM (2017). TARGETING THERAPEUTIC AND REGENERATIVE BIOMEDICINE SPECIFICALLY TO ARTHRITIC JOINTS. ANNALS OF THE RHEUMATIC DISEASES. vol. 76, A63-A63.
10.1136/annrheumdis-2016-211053.9
Rizzo P, Pitocco D, Zaccardi F, Di Stasio E, Strollo R, Rizzi A, Scavone G, Costantini F et al.(2017). Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus. Diabetes/Metabolism Research and Reviews vol. 33, (2)
10.1002/dmrr.2839
Hughes C, Nissim A(2016). Progress and clinical potential of antibody-targeted therapy for arthritic damage. Expert Rev Proteomics vol. 13, (6) 539-543.
10.1080/14789450.2016.1188008
Lim NH, Vincent TL, Nissim A (2016). DETECTION OF EARLY OSTEOARTHRITIS BY IN VIVO OPTICAL IMAGING OF AN ANTIBODY SPECIFIC TO TYPE II COLLAGEN DAMAGED BY REACTIVE OXIDANTS. OSTEOARTHRITIS AND CARTILAGE. vol. 24, S54-S54.
10.1016/j.joca.2016.01.121
Lim NH, Vincent TL, Nissim A(2015). In vivo optical imaging of early osteoarthritis using an antibody specific to damaged arthritic cartilage. Arthritis Res Ther vol. 17,
10.1186/s13075-015-0898-5
Strollo R, Vinci C, Arshad MH, Perrett D, Tiberti C, Chiarelli F, Napoli N, Pozzilli P et al.(2015). Antibodies to post-translationally modified insulin in type 1 diabetes. Diabetologia vol. 58, (12) 2851-2860.
10.1007/s00125-015-3746-x
Strollo R, Vinci C, Arshad MH, Perrett D, Tiberti C, Chiarelli F, Napoli N, Pozzilli P et al. (2015). Autoantibodies to posttranslationally modified insulin in type 1 diabetes. DIABETOLOGIA. vol. 58, S102-S103.
Maggiore C, Giovannoni G, Martin JE, Nissim A (2015). Combinatorial antibody phage display libraries constructed from B-cells infiltrating brain tissue of people with progressive multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL. vol. 21, 464-465.
Cohen-Saidon C, Nechushtan H, Kahlon S, Livni N, Nissim A, Razin E(2015). A novel strategy using single-chain antibody to show the importance of Bcl-2 in mast cell survival (vol 102, pg 2507, 2003). BLOOD vol. 125, (15) 2451-2451.
10.1182/blood-2015-02-631499
Kuhle J, Gaiottino J, Leppert D, Petzold A, Bestwick JP, Malaspina A, Lu C-H, Dobson R et al.(2015). Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome. J Neurol Neurosurg Psychiatry vol. 86, (3) 273-279.
10.1136/jnnp-2013-307454
Hughes C, Sette A, Seed M, D'Acquisto F, Manzo A, Vincent TL, Lim NH, Nissim A(2014). Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potency. Arthritis Res Ther vol. 16, (4)
10.1186/ar4613
Burska AN, Hunt L, Boissinot M, Strollo R, Ryan BJ, Vital E, Nissim A, Winyard PG et al.(2014). Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis. MEDIATORS OF INFLAMMATION vol. 2014, Article ARTN 492873,
10.1155/2014/492873
Ryan BJ, Nissim A, Winyard PG(2014). Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases. Redox Biol vol. 2, 715-724.
10.1016/j.redox.2014.05.004
Kuhle J, Plattner K, Bestwick JP, Lindberg RL, Ramagopalan SV, Norgren N, Nissim A, Malaspina A et al.(2013). A comparative study of CSF neurofilament light and heavy chain protein in MS. Mult Scler vol. 19, (12) 1597-1603.
10.1177/1352458513482374
Strollo R, Ponchel F, Malmström V, Rizzo P, Bombardieri M, Wenham CY, Landy R, Perret D et al.(2013). Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis. Arthritis Rheum vol. 65, (7) 1702-1712.
10.1002/art.37964
Rizzo P, Pitocco D, Scavone G, Di Stasio E, Costantini F, Strollo R, Galli M, Pozzilli P et al. (2013). The Role of Collagen Neoepitopes Generated by Oxidative Stress in the Pathogenesis of Charcot Neuroarthropathy. DIABETES. vol. 62, A619-A619.
Maggiore C, Giovannoni G, Martin J, Nissim A(2013). Construction of an antibody phage display library from B-cells infiltrating brain tissue of people with progressive multiple sclerosis. JOURNAL OF NEUROLOGY vol. 260, S39-S39.
Eggleton P, Nissim A, Ryan BJ, Whiteman M, Winyard PG(2013). Detection and isolation of human serum autoantibodies that recognize oxidatively modified autoantigens. Free Radic Biol Med vol. 57, 79-91.
10.1016/j.freeradbiomed.2012.11.006
Strollo R, Rizzo P, Spoletini M, Landy R, Hughes C, Ponchel F, Napoli N, Palermo A et al.(2013). HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus. Diabetologia vol. 56, (3) 563-572.
10.1007/s00125-012-2780-1
Gaiottino J, Norgren N, Dobson R, Topping J, Nissim A, Malaspina A, Bestwick JP, Monsch AU et al.(2013). Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS One vol. 8, (9)
10.1371/journal.pone.0075091
https://qmro.qmul.ac.uk/xmlui/handle/123456789/54859
Man YKS, DiCara D, Chan N, Vessillier S, Mather SJ, Rowe ML, Howard MJ, Marshall JF et al.(2013). Structural guided scaffold phage display libraries as a source of bio-therapeutics. PLoS One vol. 8, (8)
10.1371/journal.pone.0070452
Wythe SE, DiCara D, Taher TEI, Finucane CM, Jones R, Bombardieri M, Man YKS, Nissim A et al.(2013). Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide. Ann Rheum Dis vol. 72, (1) 129-135.
10.1136/annrheumdis-2012-201457
Winyard PG, Nissim A, Ryan B, Whiteman M, Eggleton P(2012). Measurement of serum autoantibodies against oxidatively modified autoantigens in human autoimmune diseases. FREE RADICAL BIOLOGY AND MEDICINE vol. 53, S64-S65.
10.1016/j.freeradbiomed.2012.08.555
Hughes C, Faurholm B, Dell'Accio F, Manzo A, Seed M, Eltawil NM, Amarrelli A, Al-Kashi A et al. (2012). TARGETING THERAPEUTICS TO ARTHRITIC JOINTS BY ANTIBODY SPECIFIC TO POST-TRANSLATIONALLY MODIFIED COLLAGEN TYPE II. ANNALS OF THE RHEUMATIC DISEASES. vol. 71,
10.1136/annrheumdis-2011-201230.16
Harel D, Marron A, Nissim A, Weiss G, IEEE (2012). A Software Engineering Framework for Switched Fuzzy Systems. 2012 IEEE INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS (FUZZ-IEEE).
Kamperidis P, Kamalati T, Ferrari M, Jones M, Garrood T, Smith MD, Diez-Posada S, Hughes C et al.(2011). Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis. Arthritis Rheum vol. 63, (12) 3758-3767.
10.1002/art.30650
Hughes C, Faurholm B, Dell'Accio F, Manzo A, Seed M, Al-Kashi A, Winyard P, Chernajovsky Y et al. (2011). Targeting therapeutics to arthritic joints. IMMUNOLOGY. vol. 135, 189-189.
Kamperidis P, Kamalati T, Ferrari M, Lee L, Jones R, Garrood T, Smith MD, Diez-Posada S et al. (2011). Development of a Novel Recombinant Biotherapeutic with Applications in Targeted Therapy of Human Arthritis. ARTHRITIS AND RHEUMATISM. vol. 63, S499-S499.
Winyard PG, Ryan B, Eggleton P, Nissim A, Taylor E, Lo Faro ML, Burkholz T, Szabó-Taylor KE et al.(2011). Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint disease. Biochem Soc Trans vol. 39, (5) 1226-1232.
10.1042/BST0391226
Hughes C, Faurholm B, Dell'Accio F, Manzo A, Seed M, Eltawil N, Marrelli A, Gould D et al. (2011). TARGETING THERAPEUTICS TO ARTHRITIC JOINTS. RHEUMATOLOGY. vol. 50, 127-127.
Anger J, Rogo-Gupta L, Behniwal A, Rashid R, Nissim A, Le T, Smith A, Litwin M et al. (2011). IS "OAB-DRY" REALLY DRY?. NEUROUROLOGY AND URODYNAMICS. vol. 30, 261-262.
Eggleton P, Ryan B, Brown S, Johnson S, Viner N, Nissim A, Isenberg D, Haigh R et al.(2011). POST-TRANSLATIONAL MODIFICATIONS OF C1Q LEAD TO ANTIGENICITY AND BREAKDOWN OF IMMUNE TOLERANCE IN SYSTEMIC LUPUS ERYTHEMATOSUS. CLIN EXP RHEUMATOL vol. 29, (1) 176-176.
Hendler A, Mulli TK, Hughes FJ, Perrett D, Bombardieri M, Houri-Haddad Y, Weiss EI, Nissim A(2010). Involvement of autoimmunity in the pathogenesis of aggressive periodontitis. J Dent Res vol. 89, (12) 1389-1394.
10.1177/0022034510381903
Nissim A, DiCara D(2010). Methods for Development of Monoclonal Antibody Therapeutics. Targeted Radionuclide Therapy, Editors: Speer, TW, Lippincott Williams and Wilkins
Hughes C, Faurholm B, Dell'Accio F, Manzo A, Seed M, Eltawil N, Marrelli A, Gould D et al.(2010). Human single-chain variable fragment that specifically targets arthritic cartilage. Arthritis Rheum vol. 62, (4) 1007-1016.
10.1002/art.27346
https://qmro.qmul.ac.uk/xmlui/handle/123456789/19241
Wythe SE, DiCara D, Finucane C, Man S, Jones R, Nissim A, Mather SJ, Chernajovsky Y et al. (2010). TARGETING THE INFLAMED MICROVASCULATURE IN RHEUMATOID ARTHRITIS. RHEUMATOLOGY. vol. 49, I12-I13.
Ryan B, Eggleton P, Brown S, Viner N, Nissim A, Isenberg D, Haigh R, Winyard PG (2010). Oxidative and Nitrative Modification of C1q Affects its Structure, Function and Antigenicity in Systemic Lupus Erythematosus. FREE RADICAL BIOLOGY AND MEDICINE. vol. 49, S148-S148.
10.1016/j.freeradbiomed.2010.10.415
Ryan B, Winyard PG, Viner N, Haigh R, Haas M, Nissim A, Isenberg D, Eggleton P (2009). OXIDATIVE MODIFICATIONS TO C1Q INCREASE THE SENSITIVITY OF AN ANTI-C1Q ELISA IN THE DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS. RHEUMATOLOGY. vol. 48, I2-I2.
Maggiore C, Meier UC, Marta M, Nissim A, Giovannoni G (2009). B Cells and EBV Infection in People with MS. NEUROLOGY. vol. 72, A37-A37.
https://qmro.qmul.ac.uk/xmlui/handle/123456789/7010
Maggiore C, Trillo-Pazos G, Keir G, Pizzolato G, Edomi P, Nissim A, Giovannoni G (2008). Ectopic germinal centres in the brain of people with multiple sclerosis. MULTIPLE SCLEROSIS. vol. 14, S231-S231.
Nissim A, Chernajovsky Y(2008). Historical development of monoclonal antibody therapeutics.
Nissim A (2008). NOVEL ANTIBODY AND USE IN DIAGNOSIS AND THERAPY OF ARTHROPATHIES.
Ryan B, Szestakowska D, Viner N, Haigh R, Haas M, Nissim A, Isenberg D, Winyard P et al. (2007). Autoantibodies target oxidatively modified proteins of the C1q/calreticulin/CD91 apoptotic pathway in systemic lupus erythematosus. ANNALS OF THE RHEUMATIC DISEASES. vol. 66, 315-315.
Brunton F, Lee L, Nissim A, Grigoriadis AE, Pitzalis C (2007). Targeting osteoclasts in rheumatoid arthritis via the alpha(v)beta(3) integrin. JOURNAL OF BONE AND MINERAL RESEARCH. vol. 22, 1113-1113.
Kamperidis PS, Lee L, Blades M, Garrood T, Nissim A, George A, Pitzalis C (2007). Identification of single-chain antibody fragments specific for human synovial microvascular endothelium by in vivo phage display. ANNALS OF THE RHEUMATIC DISEASES. vol. 66, A12-A13.
Brunton F, Lee L, Nissim A, Grigoriadis A, Pitzalis C (2007). Modulating osteoclast function by targeting the alphavbeta3 integrin. ANNALS OF THE RHEUMATIC DISEASES. vol. 66, A19-A19.
Nissim A, Chernajovsky Y(2007). Therapeutic Antibodies. Editors: Nissim, A, Chernajovsky, Y, Springer (Berlin),
Eggleton P, Szestakowska D, Winyard PG, Viner N, Nissim A (2006). Generation of neo-antigenic epitopes recognised by autoimmune sera after the post-translational modification of human C1q by free radicals. RHEUMATOLOGY. vol. 45, I103-I103.
Winyard PG, Nissim A, Davies C, Rocks S, Benjamin N (2006). Nitrosative stress in the inflamed joints of rheumatoid arthritis patients. FREE RADICAL RESEARCH. vol. 40, S111-S111.
Szestakowska D, Young P, Morse R, Viner N, Isenberg D, Nissim A, Eggleton P, Winyard P (2006). Role of oxidative protein modifications in the generation of neoantigens recognised by lupus patient sera. FREE RADICAL RESEARCH. vol. 40, S115-S115.
Nissim A, Winyard PG, Corrigall V, Fatah R, Perrett D, Panayi G, Chernajovsky Y(2005). Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint. Arthritis Rheum vol. 52, (12) 3829-3838.
10.1002/art.21479
Yudkoff M, Daikhin Y, Nissim A, Horyn O, Luhovyy B, Lazarow A, Nissim I(2005). Brain amino acid requirements and toxicity: The example of leucine (vol 135, pg 1531S, 2005). J NUTR vol. 135, (8) 2009-2009.
Horyn O, Luhovyy B, Lazarow A, Daikhin Y, Nissim A, Yudkoff M, Nissim I(2005). Biosynthesis of agmatine in isolated mitochondria and perfused rat liver: studies with N-15-labelled arginine. BIOCHEM J vol. 388, 419-425.
10.1042/BJ20041260
Nissim A, Winyard P, Davis C, Cohen G, Chernajovsky Y (2005). Development of human antibody fragments against collagen type II autoantigens in rheumatoid arthritis, using phage display libraries. RHEUMATOLOGY. vol. 44, I43-I44.
Inglis JJ, Nissim A, Lees DM, Hunt SP, Chernajovsky Y, Kidd BL(2005). The differential contribution of tumour necrosis factor to thermal and mechanical hyperalgesia during chronic inflammation. Arthritis Res Ther vol. 7, (4) R807-R816.
10.1186/ar1743
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18144
Nissim A, Winyard P, Fatah R, Perrett D, Chernajovsky Y, Panayi G, Corrigall V (2004). Generation of neo-antigenic epitopes after the post-translational modification of type II collagen by factors present within the inflamed joint. ARTHRITIS AND RHEUMATISM. vol. 50, S223-S223.
Nissim A, Gofur Y, Vessillier S, Adams G, Chernajovsky Y(2004). Methods for targeting biologicals to specific disease sites. Trends Mol Med vol. 10, (6) 269-274.
10.1016/j.molmed.2004.04.003
NISSIM A, Nechushtan H, Cohen-Saidon C, Razin E, Kahlon S, Livni N(2003). A novel strategy using single chain antibody to show the importance of Bcl-2 in mast cell survival. Blood vol. 102, (7) 2506-2512.
10.1182/blood-2002-12-3921
NISSIM A, Loyter A, Piller SC, Graessmann A, Krichevsky A, Zakai N(2003). Antibody Fragments Selected by Phage Display Against the Nuclear Localization Signal of the HIV-1 Vpr Protein Inhibit Nuclear Import in Permeabilized and Intact Cultured Cells. Virology vol. 305, (1) 77-92.
10.1006/viro.2002.1765
Gargir A, Ofek I, Meron-Sudai S, Tanamy MG, Kabouridis PS, Nissim A(2002). Single chain antibodies specific for fatty acids derived from a semi-synthetic phage display library. BBA-GEN SUBJECTS vol. 1569, (1-3) 167-173.
10.1016/s0304-4165(01)00245-8
Flores-Flores C, Nissim A, Shochat S, Soreq H (2002). Development of human antibody fragments directed towards synaptic acetylcholinesterase using a semi-synthetic phage display library. JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 165-179.
10.1007/978-3-7091-6139-5_16
NISSIM A, Soreq H, Flores-Flores C, Shochat S(2002). Phage display selection and characterization of myc-tagged humanized monoclonal antibodies to synaptic acetylcholinesterase. J Neural Transm. vol. 62, (Suppl) 163-177.
Gargir A, Ofek I, Hasty D, Meron-Sudai S, Tsubery H, Keisari Y, Nissim A(2001). Inhibition of anti body-dependent stimulation of lipoteichoic acid-treated human monocytes and macrophages by polyglycerolphosphate-reactive peptides. J LEUKOCYTE BIOL vol. 70, (4) 537-542.
Kjaer S, Wind T, Ravn P, Ostergaard M, Clark BFC, Nissim A(2001). Generation and epitope mapping of high-affinity scFv to eukaryotic elongation factor 1A by dual application of phage display. EUR J BIOCHEM vol. 268, (12) 3407-3415.
10.1046/j.1432-1327.2001.02240.x
Vaisman N, Nissim A, Klapper LN, Tirosh B, Yarden Y, Sela M(2000). Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display library. Immunol Lett vol. 75, (1) 61-67.
10.1016/s0165-2478(00)00278-9
Uchanska-Ziegler B, Qiao X, Volz A, Nissim A, Ziegler A(2000). Human single-chain Fv fragments specific for natural killer cell receptors from phage display libraries. Methods Mol Biol vol. 121, 219-237.
10.1385/1-59259-044-6:219
Neri D, Pini A, Nissim A(1998). Antibodies from phage display libraries as immunochemical reagents. Methods Mol Biol vol. 80, 475-500.
10.1007/978-1-59259-257-9_47
Neri D, Carnemolla B, Nissim A, Leprini A, Querze G, Balza E, Pini A, Tarli L et al.(1997). Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform. NATURE BIOTECHNOLOGY vol. 15, (11) 1271-1275.
10.1038/nbt1197-1271
Neri D, Carnemolla B, Nissim A, Leprini A, Querzè G, Balza E, Pini A, Tarli L et al.(1997). Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform. Nat Biotechnol vol. 15, (12) 1271-1275.
10.1038/nbt1197-1271
Oren-Shamir M, Levi-Nissim A(1997). UV-light effect on the leaf pigmentation of Cotinus coggygria 'Royal Purple'. SCIENTIA HORTICULTURAE vol. 71, (1-2) 59-66.
10.1016/S0304-4238(97)00073-3
Evenor D, Levi-Nissim A, Afgin L, Lilien-Kipnis H, Watad AA (1997). Regeneration of plantlets and bulblets from explants and callus of Allium aflatunense cultivars and selection from indigenous Israeli Allium ampeloprasum. FLOWER BULBS - SEVENTH INTERNATIONAL SYMPOSIUM, VOLS 1 AND 2. 325-330.
10.17660/ActaHortic.1997.430.50
Harrison JL, Williams SC, Winter G, Nissim A(1996). Screening of phage antibody libraries. Methods Enzymol vol. 267, 83-109.
10.1016/s0076-6879(96)67007-4
GRIFFITHS AD, WILLIAMS SC, HARTLEY O, TOMLINSON IM, WATERHOUSE P, CROSBY WL, KONTERMANN RE, JONES PT et al.(1994). ISOLATION OF HIGH-AFFINITY HUMAN-ANTIBODIES DIRECTLY FROM LARGE SYNTHETIC REPERTOIRES. EMBO J vol. 13, (14) 3245-3260.
10.1002/j.1460-2075.1994.tb06626.x
Nissim A, Hoogenboom HR, Tomlinson IM, Flynn G, Midgley C, Lane D, Winter G(1994). Antibody fragments from a 'single pot' phage display library as immunochemical reagents. EMBO J vol. 13, (3) 692-698.
10.1002/j.1460-2075.1994.tb06308.x
NISSIM A, HOOGENBOOM HR, TOMLINSON IM, FLYNN G, MIDGLEY C, LANE D, WINTER G(1994). ANTIBODY FRAGMENTS FROM A SINGLE POT PHAGE DISPLAY LIBRARY AS IMMUNOCHEMICAL REAGENTS. J CELL BIOCHEM203-203.
Nissim A, Schwarzbaum S, Siraganian R, Eshhar Z(1993). Fine specificity of the IgE interaction with the low and high affinity Fc receptor. J Immunol vol. 150, (4) 1365-1374.
Nissim A, Eshhar Z(1992). The human mast cell receptor binding site maps to the third constant domain of immunoglobulin E. Mol Immunol vol. 29, (9) 1065-1072.
10.1016/0161-5890(92)90038-y
Rutherford MN, Kumar A, Nissim A, Chebath J, Williams BR(1991). The murine 2-5A synthetase locus: three distinct transcripts from two linked genes. Nucleic Acids Res vol. 19, (8) 1917-1924.
10.1093/nar/19.8.1917
NISSIM A, ESHHAR Z(1991). THE MAST-CELL BINDING-SITE MAPPS TO THE 3RD CONSTANT REGION DOMAIN OF IMMUNOGLOBULIN-E. FASEB J vol. 5, (5) A1086-A1086.
Nissim A, Eshhar Z(1991). Localization of the Fc epsilon RI binding site to the third constant domain of IgE. Int Arch Allergy Appl Immunol vol. 94, (1-4) 93-95.
10.1159/000235335
Nissim A, Jouvin MH, Eshhar Z(1991). Mapping of the high affinity Fc epsilon receptor binding site to the third constant region domain of IgE. EMBO J vol. 10, (1) 101-107.
10.1002/j.1460-2075.1991.tb07925.x
Coccia EM, Romeo G, Nissim A, Marziali G, Albertini R, Affabris E, Battistini A, Fiorucci G et al.(1990). A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. Virology vol. 179, (1) 228-233.
10.1016/0042-6822(90)90292-y
Schwarzbaum S, Nissim A, Alkalay I, Ghozi MC, Schindler DG, Bergman Y, Eshhar Z(1989). Mapping of murine IgE epitopes involved in IgE-Fc epsilon receptor interactions. Eur J Immunol vol. 19, (6) 1015-1023.
10.1002/eji.1830190610
David S, Nissim A, Chebath J, Salzberg S(1989). 2'-5'-oligoadenylate synthetase gene expression in normal and murine sarcoma virus-transformed NIH 3T3 cells. J Virol vol. 63, (3) 1116-1122.
10.1128/JVI.63.3.1116-1122.1989
CHITAYAT SD, NISSIM A, COCCIA C, CHEBATH J, SALZBERG S (1987). 2-5A SYNTHETASE GENE-EXPRESSION IN NORMAL AND MSV-TRANSFORMED NIH/3T3 CELLS. JOURNAL OF INTERFERON RESEARCH. vol. 7, 730-730.
NISSIM A, COCCIA E, COHEN B, BENECH P, CHEBATH J(1987). 3 DIFFERENT 2'-5'OLIGO A SYNTHETASE GENES ARE ACTIVE IN MOUSE CELLS AND MULTIPLE FORMS OF ENZYMES ARE INDUCED BY INTERFERONS. J INTERFERON RES vol. 7, (6) 728-728.
Return to top